Eosinophilic Pulmonary Syndromes of Known Etiology
Parasitic Infection
General Comments: parasite-associated eosinophilic pneumonias represent the most common etiologies of pulmonary infiltrates with eosinophilia worldwide
Capillaria Aerophila (see Capillariasis, [[Capillariasis]])
Epidemiology: rare etiology of eosinophilic pulmonary infiltrates
Clonorchis Sinensis (see Clonorchiasis, [[Clonorchiasis]])
Epidemiology: rare etiology of eosinophilic pulmonary infiltrates
Epidemiology: rare etiology of eosinophilic pulmonary infiltrates
Schistosomiasis (see Schistosomiasis, [[Schistosomiasis]]): the manifestations of schistosomiasis in the lung vary dependent on the stage of disease
Early Acute Schistosomiasis: transient, multiple small pulmonary nodules with peripheral eosinophilia
Chronic Schistosomiasis: embolization of ova in small arteries of the lung results in granuloma formation, occlusion and remodeling of pulmonary arteries, and further pulmonary hypertension mediared by portopulmonary hypertension
Post-Treatment of Schistosomiasis: eosinophilic pneumonitis (lung shift, verminous pneumonia, reactionary Loffler-like pneumonitis) due to antigen release following treatment
Ascaris Lumbricoides (or Ascaris Suum): most common etiology of simple pulmonary eosinophilia (Loffler syndrome)
Necator Americanus
Ancylostoma Duodenale
Ancylostoma Brazliense or Canium
Entamoeba Histolytica
Fasciola Hepatica
Schistosomiasis (see Schistosomiasis, [[Schistosomiasis]]): the manifestations of schistosomiasis in the lung vary dependent on the stage of disease
Early Acute Schistosomiasis: transient, multiple small pulmonary nodules with peripheral eosinophilia
Chronic Schistosomiasis: embolization of ova in small arteries of the lung results in granuloma formation, occlusion and remodeling of pulmonary arteries, and further pulmonary hypertension mediared by portopulmonary hypertension
Post-Treatment of Schistosomiasis: eosinophilic pneumonitis (lung shift, verminous pneumonia, reactionary Loffler-like pneumonitis) due to antigen release following treatment
Strongyloides Stercoralis: simple pulmonary eosinophilia (Loffler syndrome) may occur when larvae migrate through the lungs after acute infection
Strongyloides Stercoralis Hyperinfection Syndrome (see Strongyloides Stercoralis, [[Strongyloides Stercoralis]])
Epidemiology: occurs in 20% of patients hospitalized with strongyloidiasis and coexisting chronic lung disease (COPD, asthma)
Diagnosis: rhabditiform larvae may be recovered via bronchoalveolar lavage, bronchial wash, or sputum sample
Clinical: cough/wheezing/dyspnea with bilateral patchy infiltrates and variable degree of eosinophilia
Epidemiology: case reports of eosinophilic pneumonia [Eosinophilia and pneumonitis in chronic brucellosis: a report of two cases. Ann Intern Med. 1942;16:995-1001]
Clinical: chronic cough with sputum eosinophilia (about 40%)
Normal Lung Function with Absence of Bronchial Hyperreactivity: although it may evolve over time into either fixed airflow obstruction without asthma or into true asthma
Absence of Eosinophilic Pneumonia
Gastric Cancer with Tumor-Related Production of GM-CSF and IL-5 (see Gastric Cancer, [[Gastric Cancer]])
Desquamative Interstitial Pneumonia (DIP): mild BAL eosinophilia may occur in some cases
Non-Specific Interstitial Pneumonia (NSIP): mild BAL eosinophilia may occur in some cases
Idiopathic Pulmonary Fibrosis (IPF) (see Idiopathic Pulmonary Fibrosis, [[Idiopathic Pulmonary Fibrosis]]): mild BAL eosinophilia may occur in some cases
Diagnosis: pulmonary pathologic lesions are nodules (with bronchiolocentric stellate shape) with Langerhans cells and variable numbers of eosinophils, plasma cells, and lymphocytes
Eosinophils are Usually Present in the Initial, Active Stage of the Disease: they contribute to the eosinophilic granuloma
Eosinophils are Numerous in 25% of Cases: usually located at the periphery of the lesions
Eosinophils are Rare or Absent at the Chronic Stage of the Disease
Acute Lung Transplant Rejection (Acute Cellular Lung Transplant Rejection) (see Acute Lung Transplant Rejection, [[Acute Lung Transplant Rejection]]): peripheral eosinophilia may occur with/without pulmonary infiltrates (as acute rejection may be detected by surveillance bronchoscopy with transbronchial biopsy prior to the development of pulmonary infiltrates)
Cyclophosphamide (Cytoxan) (see Cyclophosphamide, [[Cyclophosphamide]])
Cytarabine (ARA-C) (see Cytarabine, [[Cytarabine]])
Cytokine Release Syndrome (see Cytokine Release Syndrome, [[Cytokine Release Syndrome]]): occurs with the administration of specific monoclonal antibodies
Alemtuzumab (Campath, MabCampath, Campath-1H, Lemtrada) (see Alemtuzumab, [[Alemtuzumab]])
Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med 1996; 156:1565–71 [MEDLINE]
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243-50 [MEDLINE]
The cost of treating community-acquired pneumonia. Clin Ther. 1998 Jul-Aug;20(4):820-37 [MEDLINE]
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: anal- ysis of the MEDENOX Study. Arch Intern Med 2004; 164:963–8 [MEDLINE]
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59:421–7 [MEDLINE]
Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004;59:960-965 [MEDLINE]
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72 [MEDLINE]
CDC EPIC Study. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015 Jul 30;373(5):415-27. doi: 10.1056/NEJMoa1500245. Epub 2015 Jul 14 [MEDLINE]
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14 [MEDLINE]
Prevention
Facilitating influenza and pneumococcal vaccination through standing orders programs. JAMA 2003; 289:1238 [MEDLINE]
General Treatment
The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820–37 [MEDLINE]
Antibiotics
Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med. 1999;160(2):608-613 [MEDLINE]
PneumA Trial. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588-2598 [MEDLINE]
Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637–44 [MEDLINE]
Antimicrobial stewardship programs: mandatory for all ICUs. Crit Care. 2012;16:179. doi:10.1186/cc11853 [MEDLINE]
Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41:2099–2107. doi: 10.1097/CCM.0b013e31828e9863 [MEDLINE]
Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated. Chest. 2013 May;143(5):1219-25. doi: 10.1378/chest.12-1361 [MEDLINE]
Antibiotic stewardship in hospital-acquired pneumonia. Chest. 2013;143:1195–1196. doi:10.1378/chest.12-2729 [MEDLINE]
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA. 2014 Jun 4;311(21):2199-208. doi: 10.1001/jama.2014.4304 [MEDLINE]
What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 2014; 40:92–5 [MEDLINE]
CAP-START Trial. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015 Apr 2;372(14):1312-23. doi: 10.1056/NEJMoa1406330 [MEDLINE]
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. Clin Infect Dis. 2016 Apr 15;62(8):1009-17. doi: 10.1093/cid/civ1199. Epub 2015 Dec 23 [MEDLINE]
Duration of Antibiotic Treatment in Community-Acquired Pneumonia
A Multicenter Randomized Clinical Trial. JAMA Intern Med. 2016 Jul 25. doi: 10.1001/jamainternmed.2016.3633 [MEDLINE]
Corticosteroids
Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. J Hosp Med. 2013 Feb;8(2):68-75 [MEDLINE]
Respiratory Support
Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1585-91 [MEDLINE]
Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success. Thorax. 1995 Jul;50(7):755-7 [MEDLINE]
Predictors of failure of noninvasive ventilation in patients with severe community-acquired pneumonia. J Crit Care. 2010 Sep;25(3):540.e9-14. doi: 10.1016/j.jcrc.2010.02.012 [MEDLINE]
The role of noninvasive positive pressure ventilation in community-acquired pneumonia. J Crit Care. 2015 Feb;30(1):49-54. doi: 10.1016/j.jcrc.2014.09.021. Epub 2014 Oct 2 [MEDLINE]
Prognosis
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis. 2013 Aug;57(3):362-7 [MEDLINE]
Editorial commentary: “excess readmissions” for pneumonia: a dilemma with a penalty. Clin Infect Dis. 2013 Aug;57(3):368-9 [MEDLINE]